CytomX Therapeutics, Inc. (CTMX)
4.89
+0.33
(+7.24%)
USD |
NASDAQ |
Apr 16, 16:00
4.89
0.00 (0.00%)
After-Hours: 17:07
CytomX Therapeutics Cash from Investing (TTM) : -59.74M for Dec. 31, 2025
Cash from Investing (TTM) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
Cash From Investing Definition
Cash from Investing is a major line item of the statement of cash flows. This metric tracks the movement of cash flows for the overall investing activities of the company. A few examples of investing activities include net change in PP&E, and net divestitures.
Cash from Investing (TTM) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Cash from Investing (TTM) Benchmarks
| Catalyst Pharmaceuticals, Inc. | -0.058M |
| Rigel Pharmaceuticals, Inc. | -92.36M |
| REGENXBIO, Inc. | -15.87M |
| Ovid Therapeutics, Inc. | -49.85M |
| Olema Pharmaceuticals, Inc. | -155.76M |